Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming

Area of Science:

• Immunology
• Allergy and Asthma Research
• Prostaglandin Signaling

Background:

• Regulatory T cells (Tregs) are essential for immune homeostasis and preventing allergic airway inflammation.
• Prostaglandin I2 (PGI2) has previously shown potential in promoting immune tolerance during allergic inflammation.
• The specific role of PGI2 in regulating Treg function remained uninvestigated.

Purpose of the Study:

• To investigate the effect of PGI2 on the suppressive function of regulatory T cells (Tregs).
• To explore the mechanisms by which PGI2 influences Treg phenotype and function.
• To evaluate the therapeutic potential of PGI2 in allergic airway inflammation models and human asthma.

Main Methods:

• Comparison of Treg function in PGI2 receptor IP knockout (IP KO) mice versus wild-type (WT) mice during allergic airway inflammation.
• Analysis of immunoglobulin-like transcript 3 (ILT3) expression on Tregs.
• Utilized fate-mapping mice to track Treg reprogramming.
• Investigated the effect of PGI2 analogs on naive T cell differentiation into Tregs in mice and humans, including β-catenin signaling pathway analysis.
• Examined the association of an IP missense variant with chronic obstructive asthma in humans.

Main Results:

• IP KO Tregs exhibited impaired suppressive capabilities in allergic airway inflammation.
• IP KO Tregs showed significantly enhanced expression of ILT3 compared to WT Tregs.
• PGI2 signaling was found to prevent Treg reprogramming towards a pathogenic phenotype.
• PGI2 analogs promoted naive T cell differentiation into Tregs by repressing β-catenin signaling.
• A human IP missense variant was strongly associated with chronic obstructive asthma.

Conclusions:

• PGI2 signaling is critical for licensing the suppressive function of regulatory T cells (Tregs).
• PGI2 plays a protective role by preventing Treg reprogramming and promoting their differentiation.
• PGI2 represents a promising therapeutic target for enhancing Treg function and treating allergic airway diseases like asthma.